Flagship blends three biotech startups to form Etcelera

T2Covered by 1 source · first reported by BioPharma Dive / Healthcare Dive / MedTech Dive at 29 Oct, 10:30 UTC

Etiome, Cellarity and Empress Therapeutics are being combined into one new AI-aided drugmaker claiming to possess the ability to better predict the way new medicines will fare in humans.